Viewing nowCombinationNeostar Tablet 80/5 mg
Telmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.

MFDS item code 201804442 · Approved 2018.11.08 · Insurance code 653805350
Treatment of essential hypertension not controlled with monotherapy
In patients with essential hypertension, when blood pressure is not adequately controlled with Telmisartan or Amlodipine monotherapy, this medicine can be added to achieve more effective blood pressure control.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended to adjust the dose using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ◦ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. However, for patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In older adults aged 75 years and over, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication can pose a serious risk to the fetus during pregnancy, particularly in the second and third trimesters, so women who are pregnant or may become pregnant should not take this medicine. This drug should not be administered to individuals allergic to the active ingredient or similar components, patients with obstructive biliary disease, severe hepatic impairment, significant cardiovascular disease, pregnant women, breastfeeding mothers, and certain other patients. Patients with impaired hepatic or renal function, heart valve disease, and the elderly must exercise special caution when using this medication, which may require dose adjustments or regular monitoring. Common side effects may include dizziness, swelling, and hypotension, while rare but serious adverse events may include severe allergic reactions or cardiovascular events, necessitating immediate consultation with a healthcare professional if unusual symptoms arise. Regular monitoring of blood pressure, renal function, and serum potassium levels is necessary during the course of treatment to ensure no abnormalities occur. Interactions may arise when combined with other medications, so patients should inform healthcare professionals of any concurrent medications, especially diuretics, potassium supplements, lithium, digoxin, or warfarin. If planning to conceive or during pregnancy, this medication should be discontinued, and it is also not recommended for breastfeeding mothers. Elderly patients may be more sensitive to this medication, and treatment should begin at a lower dose while closely monitoring their condition. Overdose can lead to symptoms such as hypotension, dizziness, and arrhythmias, and immediate medical attention is required for appropriate care. This medication has not been proven safe and effective in children, so it is not recommended for use in this population.
Not everyone experiences these, and they can vary from person to person.
This medicine is sensitive to light and should be stored in a dark container, ideally at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the effectiveness of the drug and prevents degradation.
Bicolored oval double tablet, one side white and the other light blue, convex on both sides.
30 tablets (10 tablets/PTP*3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.